TNBC
Clinical trials for TNBC explained in plain language.
Never miss a new study
Get alerted when new TNBC trials appear
Sign up with your email to follow new studies for TNBC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug enzelkitug enters first human trials
Disease control OngoingThis early-phase trial is testing a new drug called enzelkitug, alone or with standard immunotherapies, in people with advanced solid tumors that have not responded to other treatments. The main goals are to check safety, find the right dose, and see if the drug shrinks tumors. A…
Matched conditions: TNBC
Phase: PHASE1 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New hope for tough breast cancer: drug combo trial launches
Disease control ENROLLING_BY_INVITATIONThis study tests a new drug called HB0025 combined with chemotherapy (nab-paclitaxel) as a first treatment for people with advanced triple-negative breast cancer that cannot be removed by surgery. The goal is to see if the combination is safe and works better than chemotherapy al…
Matched conditions: TNBC
Phase: PHASE2 • Sponsor: Huabo Biopharm Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC